Stock NXGL NEXGEL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases NEXGEL, Inc.

Equities

NXGL

US65344E1073

Market Closed - Nasdaq
Other stock markets
 20:57:40 27/06/2024 BST 		5-day change 1st Jan Change
2.175 USD -2.03% Intraday chart for NEXGEL, Inc. +5.07% +2.11%
06-27 NEXGEL Secures Distribution Deal for SilverSeal Wound Dressing With Cintas MT
06-27 Nexgel, Inc. to Supply Silverseal to Cintas Corporation CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation
AQ
NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America
AQ
NEXGEL Acquires International Beauty Brand, Silly George
AQ
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
AQ
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
AQ
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024
AQ
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
AQ
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
AQ
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
AQ
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
AQ
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
AQ
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
AQ
NEXGEL to Present at The Microcap Conference, January 30th through February 1st
AQ
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
AQ
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
AQ
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line
AQ
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
AQ
NEXGEL to Report Third Quarter 2023 Financial Results on November 13th
AQ
NEXGEL Secures Supply Agreement with AbbVie
AQ
NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NXGL Stock
  4. News NEXGEL, Inc.
  5. Press Releases